A popular term for the common clinical association of type 2 diabetes mellitus and obesity. These two conditions have reached epidemic proportions and they not only share the same underlying causes but require similar treatment.
Diabesity has already become a worldwide epidemic with a significant health and economic burden affecting both developed and developing countries. Every obese person is at a high risk of acquiring type 2 Diabetes.
Common medical complications associated with Diabesity include:-
- Coronary Heart Disease,
- Stroke/Cerebral Vascular Accident,
- DVT and pulmonary embolism,
- Sleep apnea
- Peripheral Vascular Disease
- Gastroesophageal reflux
- Gallbladder Disease
- Fatty Liver
- Erectile Dysfunction
- Breast/bowel/prostate/endometrial/kidney/esophageal/liver/pancreatic cancer.
Diabesity is defined as a constellation of signs that constitutes what is commonly referred to as metabolic syndrome characterized by:-
- Central obesity. (defined as waist circumference ≥ 40 inches for men and ≥ 35cm for women)
- Dyslipidemia:-i.e. raised Total lipid levels, high LDL&reduced HDL cholesterol.
- High blood pressure.
- High blood sugar/ or previously diagnosed type 2 diabetes
For most people, neither dieting nor current pharmacological interventions are effective in achieving long-term weight reduction. To treat Diabesity, approaches must be developed to modulate the ways in which the brain controls metabolism, body weight and composition.
The most effective long-term treatment is Bariatric/ Weight loss surgery which includes procedures such as:-
- Laparascopic adjustable gastric banding (LAGB).
- Vertical Banded Gastroplasty.
- Biliopancreatic diversion with duodenal switch.
- Roux- en- Y Gastric Bypass.
- Vertical Sleeve Gastrectomy.